Andrew Flies completed a BSc in Computer Science at Minnesota State University, Mankato in 2002, with minors in Chemistry and Math. He earned his PhD from Michigan State University in Dec 2012. His focus since 2014 has been on the development of vaccines and immunology tools for Tasmanian devils. He currently an ARC Future Fellow and Associate Professor at the Menzies Institute for Medical Research at the University of Tasmania and leads the Wild Immunology Group. His team is developing a viral vector-based vaccine that can be distributed in edible baits to vaccinate wild devils in the Tasmanian landscape.